# Crescent Biopharma, Inc. (GLYC) — Net Income

## Annual Net Income (USD)

| Year | Net Income |
| --- | --- |
| 2024 | -$38M |
| 2023 | -$37M |
| 2022 | -$47M |
| 2021 | -$63M |
| 2020 | -$51M |
| 2019 | -$58M |

## Quarterly Net Income (USD)

| Quarter | Net Income |
| --- | --- |
| 2025-03-31 | -$2M |
| 2024-12-31 | -$7M |
| 2024-09-30 | -$10M |
| 2024-06-30 | -$10M |
| 2024-03-31 | -$11M |
| 2023-12-31 | -$9M |

Source: [CompaniesByCap](https://companiesbycap.com/company/GLYC/net-income)